Tchum, Samuel Kofi
Sakyi, Samuel Asamoah
Arthur, Fareed
Adu, Bright
Abubakar, Latifatu Alhassan
Oppong, Felix Boakye
Dzabeng, Francis
Amoani, Benjamin
Gyan, Thomas
Asante, Kwaku Poku
Article History
Received: 9 May 2022
Accepted: 11 March 2023
First Online: 23 March 2023
Declarations
:
: Ethics approval for the original clinical trial was obtained from the Ghana Health Service (GHS).Ethical Review Committee, Food and Drugs Authority (FDA) of Ghana, Kintampo Health.Research Centre (KHRC) Institutional Ethics Committee Institutional Ethics Committee and Hospital for Sick Children (SickKids) Research Ethics Board, Canada. The secondary analysis of trial data, as well as the primary analysis of immunogenetic data, were approved by the SickKids.Research Ethics Board and KHRC Institutional Ethics Committee Institutional Ethics Committee. Informed consent was obtained from each participant’s primary caregiver before screening and enrolment in the trial.
: Not applicable.
: The authors declare that they have no competing interests.